INSM Competitors & Alternatives
Compare Insmed Inc with similar stocks in the same industry
Biotechnology
INSM
Main Stock$105.54
Tradestie Score
52
Market Cap
$31.13B
Revenue Growth
2.3%
Analyst Upside
+94.0%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ONC
BeOne Medicines Ltd. American Depositary Shares
|
$293.34
|
$36.81B | 68.9 | 51 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$88.12
|
$24.57B | - | 48 | Compare |
|
GMAB
Genmab A/S ADS
|
$26.48
|
$19.56B | 20.4 | 50 | Compare |
|
INCY
Incyte Genomics Inc
|
$95.39
|
$16.93B | 13.8 | 53 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$52.70
|
$15.70B | 28.1 | 69 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$16.00
|
$15.22B | - | 50 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$235.40
|
$12.36B | 27.2 | 60 | Compare |
|
EXEL
Exelixis Inc
|
$50.22
|
$11.09B | 16.9 | 63 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$28.55
|
$10.76B | - | 64 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$48.31
|
$10.74B | - | 57 | Compare |
More INSM Analysis
Data updated: May 18, 2026 | Industry: Biotechnology (SIC 2834)
227 stocks in this industry